Thorne Launches NiaCel Featuring NIAGEN from ChromaDex

Thorne Research announced the launch of NiaCel, a nutritional supplement that supports endurance, energy  and healthy aging that features the ingredient NIAGEN from ChromaDex Corp.

ChromaDex developed the patent-protected ingredient as the first commercially available brand of nicotinamide riboside (NR). NR, the active ingredient in NiaCel, boosts levels of NAD+ (nicotinamide adenine dinucleotide) in cells. A 2013 study found that increased levels of NAD+ helped support healthy aging by stimulating mitochondrial energy production (Cell. 2013 Dec 19;155(7):1624-38).

"We are very excited to offer NIAGEN nicotinamide riboside to our practitioner network through this new, exclusive product launch.  NiaCel provides practitioners with a powerful new solution to promote healthy aging in patients," said Paul Jacobson, CEO of Thorne Research. " NIAGEN is one of the most innovative new ingredients developed in the past decade.  We are thrilled to partner together with ChromaDex and our practitioner-customer base to enhance patient health with the introduction of NiaCel."